$ATXI I've been researching this all morning and I really think this dive is a market overreaction to the FDA CRL. Delays and corrections are to be expected when you're dealing with a lengthy bureaucratic approval process like this, and there's no evidence the drug is any less promising than it was when this was at $10 a couple days ago. I think panic sellers are going to look back on this and regret their decision.